Literature DB >> 8693546

Liver dysfunction in allogeneic bone marrow transplantation recipients.

N Azar1, D Valla, I Abdel-Samad, C Hoang, C Fretz, L Sutton, J J Fournel, Y Le Charpentier, J L Binet, V Leblond.   

Abstract

Liver dysfunction is common in allogeneic bone marrow graft recipients, but no systematic studies of pre- and posttransplantation liver biopsies have been performed to identify and compare hepatic lesions. This study involved 25 consecutive patients who had undergone serial viral screening tests, liver tests, and pre- and posttransplantation liver biopsy. The aims were to ascertain the origin of liver disorders prior to bone marrow transplantation, to determine the mechanism and severity of liver dysfunction occurring early after transplantation, and to identify a possible relationship between pre-existing liver lesions and the frequency and nature of early liver dysfunction after transplantation. Pretransplantation biochemical liver tests were abnormal in 72% of patients, despite the absence of clinical liver disease. Eleven patients had chronic viral hepatitis B or C. Mild or moderate histological lesions were present in all the patients, with bile duct abnormalities in 48%, central vein abnormalities in 24%, sinusoidal fibrosis in 52%, portal fibrosis in 88%, portal necrosis in 52%, and parenchymal siderosis in 76%. After transplantation, fatal veno-occlusive disease occurred in two patients and biochemical abnormalities occurred in 24. Coded review of needle biopsy specimens failed to provide a single diagnosis. Histological lesions differed between pre- and posttransplantation biopsy specimens only by increased iron overload (96%, P<0.01). We conclude that pretransplant liver lesions contribute to hepatic dysfunction early after bone marrow transplantation, being very similar in nature and degree to lesions observed posttransplantation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693546     DOI: 10.1097/00007890-199607150-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.

Authors:  John Koreth; Joseph H Antin
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 3.  Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.

Authors:  Erden Atilla; Selami K Toprak; Taner Demirer
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831

Review 4.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.